Syndax Pharmaceuticals Inc (SNDX) — Cash Flow Reinvestment Rate
Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow Reinvestment Rate of 0.60x as of December 2021, reinvesting $59.96 Million (capex $129.00K plus investments $-59.83 Million) from operating cash flow of $100.71 Million. See cash generation quality of Syndax Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Syndax Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Syndax Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Syndax Pharmaceuticals Inc (SNDX) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Syndax Pharmaceuticals Inc. See Syndax Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.40x | $40.87 Million | $29.13 Million | $129.00K | — |